AB
CHRS icon

Amalgamated Bank’s Coherus Oncology CHRS Stock Holding History

Amalgamated Bank’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,332
Closed -$5K – 1857
2025
Q4 		$5K Sell
3,332
-277
-8% -$404 ﹤0.01% 2699
2025
Q3 		$6K Hold
3,609
– – ﹤0.01% 2663
2025
Q2 		$3K Hold
3,609
– – ﹤0.01% 2900
2025
Q1 		$3K Hold
3,609
– – ﹤0.01% 2773
2024
Q4 		$5K Hold
3,609
– – ﹤0.01% 2711
2024
Q3 		$4K Hold
3,609
– – ﹤0.01% 2802
2024
Q2 		$6K Buy
3,609
+1,029
+40% +$2.07K ﹤0.01% 2675
2024
Q1 		$6K Sell
2,580
-10,844
-81% -$26.7K ﹤0.01% 2629
2023
Q4 		$45K Buy
13,424
+2,537
+23% +$6.79K ﹤0.01% 2297
2023
Q3 		$41K Sell
10,887
-20,311
-65% -$93.8K ﹤0.01% 2330
2023
Q2 		$133K Buy
31,198
+580
+2% +$3.42K ﹤0.01% 1972
2023
Q1 		$209K Sell
30,618
-2,181
-7% -$16.9K ﹤0.01% 1784
2022
Q4 		$260K Hold
32,799
– – ﹤0.01% 1758
2022
Q3 		$315K Buy
32,799
+386
+1% +$3.91K ﹤0.01% 1647
2022
Q2 		$235K Buy
32,413
+1,126
+4% +$9.79K ﹤0.01% 1802
2022
Q1 		$404K Sell
31,287
-1,931
-6% -$24.6K ﹤0.01% 1643
2021
Q4 		$530K Sell
33,218
-876
-3% -$15.3K ﹤0.01% 1548
2021
Q3 		$548K Sell
34,094
-666
-2% -$9.76K ﹤0.01% 1526
2021
Q2 		$481K Buy
+34,760
New +$492K ﹤0.01% 1664
2020
Q2 		– Sell
-10,380
Closed -$168K – 1512
2020
Q1 		$168K Sell
10,380
-432
-4% -$7.98K ﹤0.01% 1409
2019
Q4 		$195K Buy
+10,812
New +$199K ﹤0.01% 1647
2019
Q3 		– Sell
-9,950
Closed -$220K – 1783
2019
Q2 		$220K Buy
+9,950
New +$173K 0.01% 1529

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Amalgamated Bank's CHRS Position: Q1 2026 in Review

Amalgamated Bank sold out of Coherus Oncology (CHRS) in Q1 2026, closing a stake of 3,332 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in CHRS in Q2 2019 and held it in 22 quarters. The position peaked at $548K in Q3 2021. 158 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Amalgamated Bank reported no remaining Coherus Oncology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,332 Coherus Oncology shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Coherus Oncology in Q2 2019 and held it in 22 quarters.
  • Amalgamated Bank's Coherus Oncology position peaked at $548K in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.